Bone Marrow Transplantation and Immune Deficiency

Publications

Abdullah, S; Webster, A; Blackard, JT; Laskin, B; Seif, AE; Mccormack-Spivey, S; Luebbering, N; Walder, T; Hurst, T; Jodele, S; Davies, SM; Sabulski, A. BK Polyomavirus Escapes Immune Response and Prolongs Cell Survival through Interferon-Regulated Gait Complex and Sirtuin Signaling. Transplantation and Cellular Therapy. 2026; 32(2):s537-s538.

Abid, MB; Wudhikarn, K; Ye, Q; Martens, MJ; Mirza, A-S; Gowda, L; Devarakonda, S; Efebera, Y; Boghdadly, ZE; Dandoy, CE; Murthy, HS; Perales, M-A; Huppler, A; Auletta, JJ. Infections in Patients with Relapsed Refractory Multiple Myeloma Receiving Idecabtagene Vicleucel Therapy: A Real-World Analysis from CIBMTR. Transplantation and Cellular Therapy. 2026; 32(2):s420-s421.

Alexander, JL; Dávila Saldaña, BJ; Brazauskas, R; Dammalapati, SG; Griffith, LM; Shah, AJ; Shimano, KA; Ochs, HD; Bleesing, JJ; Ebens, CL; Cowan, MJ; Petrovic, A; Pai, S-Y; Burroughs, LM. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood advances. 2026; 10(5):1783-1798.

Alkhouli, L; Badia, P; Bakinowski, E; Craddock, J; Culbertson, C; Dandoy, CE; Davies, SM; Desalvo, AM; Gorfinkel, L; Huber, J; Patel, V; Jodele, S; Wall, S; Epling, P. Toward Standardized Screening for Chronic GVHD: Insights from the Engraft Learning Network. Transplantation and Cellular Therapy. 2026; 32(2):s252-s253.

Arnold, DE; Kaviany, S; Aluri, J; Calvo, KR; Mehta, SS; Tobin, JM; Schuettpelz, LG; Saucier, N; Schmitz, EG; Murguía-Favela, L; Pai, S-Y; Bednarski, JJ; Connelly, JA; Cooper, MA. Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function. Blood advances. 2026; 10(6):1967-1976.

Arnold, DE; Eissa, H; Dunn, E; Cuvelier, GDE; Wright, NAM; Marsh, RA; Parikh, S; Saldana, BD; Vander Lugt, MT; Bacchetta, R; Torgerson, TR; Leiding, JW; Heimall, J; Chan, AY. IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC). Journal of Allergy and Clinical Immunology: In Practice. 2026.

Arnold, DE; Leiding, JW; Logan, B; Marsh, RA; Griffith, LM; Grunebaum, E; Murguía-Favela, L; Mallhi, K; Chellapandian, D; Deal, CL; Torgerson, T; Malech, HL; Kang, EM; Parikh, S. Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report. Transplantation and Cellular Therapy. 2026; 32(1):89.e1-89.e10.

Badia, P; Alkhouli, L; Bakinowski, E; Blevins, C; Culbertson, C; Dandoy, CE; Davies, SM; Desalvo, AM; Diaz, J; Huber, J; Parker, L; Rotz, SJ; Stuckey, R; Hartley, D. A Day in the Life of the Engraft Learning Network: Bridging Perspectives and Driving Discovery. Transplantation and Cellular Therapy. 2026; 32(2):s513-s514.

Badia, P; Alkhouli, L; Blevins, C; Culbertson, C; Dandoy, CE; Davies, SM; Diaz, J; Hartley, D; Huber, J; Hunter, L; Nguyen, A; O'mathúna, D; Parker, L; Nelson, AS. The Engraft Journey Map: Co-Designing a Roadmap for Patients and Caregivers Undergoing Bone Marrow Transplant. Transplantation and Cellular Therapy. 2026; 32(2):s357-s358.

Badia, P; Langenberg, L; Ibrahimova, A; Jodele, S; Davies, SM; Khandelwal, P. Post-Transplant Cyclophosphamide GVHD Prophylaxis Has a Unique Vascular Toxicity Compared to Abatacept Containing Regimens. Transplantation and Cellular Therapy. 2026; 32(2):s591.

Bartlett, A; Romero, L; Hunter, G; French, K; Scott, SL; Dorn, K; Davies, SM. Puppy Taails Study: Perceived Utility from Patient and Parent Surveys of Therapeutic Animal Assisted Interventional Services in Pediatric Cancer and Bone Marrow Transplant Patients. Transplantation and Cellular Therapy. 2026; 32(2):s599.

Bender, JD; Pommert, L; Backus, LR; Bidwell, A; Blank, C; Breese, EH; Burns, KC; Lane, A; Lee, LH; Mizukawa, B; Ryan, TD; Young, J; Absalon, M; Perentesis, JP. CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved Dose. Pediatric Blood and Cancer. 2026; 73(6):e70268.

Boas, H; Mcdonough, J; Lane, A; Demauro, SB; Ren, CL; Josephson, M; Goldfarb, SB; Robinson, PD; Allen, JL. Normal Values for Respiratory Oscillometry in Pediatrics: An Argument for a Local Control Population. Pediatric Pulmonology. 2026; 61(3):e71508.

Boas, H; Mcdonough, J; Lane, A; Demauro, SB; Ren, CL; Josephson, M; Goldfarb, SB; Robinson, PD; Allen, JL. Cover Image, Volume 61, Number 3, March 2026. Pediatric Pulmonology. 2026; 61(3):i-i.

Boldt, A; Davies, SM; Benoit, SW. Decreased Pre-Transplant Kidney Function Is Associated with Mortality and Dialysis Needs during Pediatric Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2026; 32(2):s601-s602.

Borogovac, A; Efebera, Y; Clark, L; Houk, A; Ragon, BK; Hamilton, BK; Devine, SM; Dandoy, CE; Plasteras, J; Wall, S; Horowitz, MM; Khera, N; Juckett, MB; Bhatt, N. Clinical Decision-Making in Hematopoietic Cell Transplantation (HCT) for Severe Aplastic Anemia (SAA): Insights from a National Survey of Physicians. Transplantation and Cellular Therapy. 2026; 32(2):s318-s319.

Bota, KE; Young, K; Wall, J; Koo, J; Myers, K; Ramos, KN; Dandoy, CE; Davies, SM; Taggart, CB. Got Nutrition? Exclusion of Nutrition Intervention at Key Points during Hematopoietic Stem Cell Transplantation Negatively Impacts Frailty. Transplantation and Cellular Therapy. 2026; 32(2):s607-s608.

Brumm, VL; Kidd, SA; Logan, BR; Chunara, F; Heimall, J; Griffith, LM; Kohn, DB; Sanchez, L; Bednarski, JJ; Martinez, C; Pulsipher, MA; Puck, JM; Cowan, MJ; Shah, AJ. Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study. Journal of Human Immunity. 2026; 2(1):e20250163.

Cai, P; Liu, J; Xu, H; Wang, X; Zou, C; Zhang, L. LESA: Learnable Stage-Aware Predictors for Diffusion Model Acceleration. . 2026; abs/2602.20497.

Chandra, S; Greis, KD; Chutipongtanate, S; Luebbering, N; Webster, A; Poisson, KE; Fisher, KS; Smiley, K; Marsh, RA; Jordan, MB; Davies, SM. Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood advances. 2026; 10(4):960-972.

Chandra, S; Greis, KD; Chutipongtanate, S; Luebbering, N; Webster, A; Poisson, KE; Fisher, KS; Smiley, K; Marsh, RA; Jordan, MB; Davies, SM. Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood advances. 2026; 10(4):960-972.

Chandrakasan, S; Westbrook, A; Griffith, LM; Hagin, D; Iyengar, S; Mangurian, C; Scalchunes, C; Sullivan, KE; Zablocki, A; Bakshi, N; Torgerson, T; Cowan, MJ; Ochs, HD; Parikh, S. Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers. Clinical Immunology. 2026; 283:110658.

Clark, A; Blignaut, M; Gerlach, W; Klein, G; Kusnier, K; Maier, S; Mohr, R; Smith, H; Spears, K; Tunningley, O; Grimley, MS. Bridging the Training Gap for Nurses and Advanced Practice Providers: Addition of in-Situ Simulations for Pediatric Transplant and Cellular Therapy Emergencies. Transplantation and Cellular Therapy. 2026; 32(2):s493-s494.

Cook, E; Gloude, N; Bidgoli, A; Krogman, A; Williams, KM; Khandelwal, P. Ruxolitinib as a Steroid-Sparing Treatment for Chronic Graft-Versus-Host Disease. Transplantation and Cellular Therapy. 2026.

Cook, E; Gloude, NJ; Bidgoli, A; Krogman, A; Williams, KM; Khandelwal, P. Ruxolitinib As a Steroid-Sparing Treatment for Chronic Graft Vs Host Disease: A Case Series. Transplantation and Cellular Therapy. 2026; 32(2):s290-s291.

Cook, E; Rotz, SJ; Auletta, JJ; Bidgoli, A; Blacken, R; Johnson, D; Badia, P; French, K; Hartley, DM; Kent, GR; Schoettler, ML; Sampson, M; Dandoy, CE; Fitch, TJ. Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and Perspective. Pediatric Blood and Cancer. 2026; 73(3):e70001.

Davies, SM; Blyth, E; Bollard, CM; Craddock, J; Dahi, PB; Gottlieb, D; Grimley, MB; Keller, MD; Khoury, R; Olson, AL; Spivey, SM; Vasileiou, S; Prockop, SE; Heslop, HE. Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT. Transplantation and Cellular Therapy. 2026.

Dorn, L; Dandoy, C; Ryan, TD; Lizardi, JCV. 26-A-15331-ACC PERICARDIAL EFFUSION IS ASSOCIATED WITH CLINICAL AND SUBCLINICAL LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. Journal of the American College of Cardiology. 2026; 87(13):a1107.

Ellifson, GK; Dandoy, CE; Fabrizio, VA; Kapadia, M; Lehmann, LE; Olson, KE; Puranik, CP; Treister, N; Thikkurissy, S; Chin, K. Assessment of Oral Health Practices for Patients Receiving Stem Cell Transplantation at Pediatric Oncology Centers. Transplantation and Cellular Therapy. 2026; 32(2):s315-s316.

Galletta, TJ; Rubinstein, JD; Dandoy, CE; Khoury, R; Faulhaber, A; Phillips, CL; Krupski, C. Emapalumab for Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CD19-Directed CAR-T in Two Patients With B-ALL: Clinical and Biomarker Correlates. Pediatric Blood and Cancer. 2026; e70406.

Galletta, TJ; Rubinstein, JD; Krupski, C; Dandoy, CE; Khoury, R; Faulhaber, A; Davies, SM; Phillips, CL. Biomarker Elevations Associated with Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome after CD19-Directed CAR-T Therapy in Children and Young Adults with Acute B-Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 2026; 32(2):s177.

Ghalehsari, N; Pandey, M; Auletta, JJ; Beaver, E; Davies, SM; Espinoza-Gutarra, MR; Fraint, E; Holter-Chakrabarty, J; Howard, D; Knutson, J; Ramos, KN; Shah, R; Hall, AG; Gomez-Arteaga, A. Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients. Transplantation and Cellular Therapy. 2026; 32(1):12.e1-12.e4.

Gibson, NM; Nguyen, N; Amaral, S; Hsu, J; Haney, M; Heimbruch, KE; Sabulski, A; Zurawel, A; Davidow, KA; Lind, KT; Hall, L; Bailey, LC; Olson, TS; Kwiatkowski, JL. Impact of iron overload on hematopoietic stem cell transplantation in pediatric patients with nonmalignant hematological disorders. Blood advances. 2026; 10(10):3324-3334.

Gloude, NJ; Brundige, K; Loveless, S; Atkinson, I; Chandra, S; Cooper, R; Coyne, K; Dusa, C; Galvin, A; Geddis, A; Millecker, J; Walkovich, K; Shimamura, A; Myers, KC. Beyond neutropenia: Immunological evaluation of patients with Shwachman-Diamond syndrome. British Journal of Haematology. 2026; 209(1):180-188.

Goldfarb, SB; Gupta, A; Shanley, R; Josephson, M; Freedman, J; Towe, C; Davies, SM; Myers, K. B105-09 Bridging Diagnostic Gaps in Pediatric BOS: Clinical Relevance of Pediatric ATS BOS Criteria Post-HSCT. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.2623.

Gonzalez, CE; Fletcher, A; Jenkins, TL; Zahraeifard, S; Peterson, R; Taylor, M; Jones, C; Urban, A; Avila, D; Campillay, M; Pai, S-Y; Grimley, M; Freeman, AF; Cortese, I. Resolution of PML after Treatment with Virus-Specific T Cells and HCT. New England Journal of Medicine. 2026; 394(20):2061-2064.

Grupp, SA; Grimley, MS; Driscoll, T; Mahadeo, KM; Leonard, A; Wang, Y; Phillips, H; Justus, D; Lehmann, LE; Esrick, E; Tisdale, JF; Sharma, A; Crees, ZD; Manis, J. Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide. Transplantation and Cellular Therapy. 2026; 32(2):s20-s21.

Guerrettaz, R; Peterson, A; Allbee-Johnson, M; Ahn, KW; Rotz, SJ; Sharma, A; Im, A; Nuechterlein, B; Ahmed, S; Mehta, PA; Phillips, CL; Higgins, R; Broglie, L; Phelan, R. Outcomes of Allogeneic Stem Cell Transplantation In the Adolescent and Young Adult Population with Acute Lymphoblastic Leukemia Based on Transplant Center: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study. Transplantation and Cellular Therapy. 2026; 32(2):s112.

Guilcher, GMT; Dalal, S; Suresh, T; Yelamali, AR; Arora, J; Aljayyousi, H; Bhatia, M; Haight, AE; Khandelwal, P; Khoury, R; Shah, NC; Stenger, EO; Yelamanchili, N; Shenoy, S. Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease. Transplantation and Cellular Therapy. 2026; 32(6):709.e1-709.e10.

Hahn, T; Zhao, Q; Miller, EG; Elder, P; Langenberg, L; Luebbering, N; Abdullah, S; Neidemire-Colley, L; Holtan, SG; Cataland, SR; Ranganathan, P; Davies, SM; Bejanyan, N; Vasu, S. TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium study. Blood advances. 2026.

Hare, K; Hudda, Z; Wassmer, T; Winograd, DR; Klink, G; Myers, K; Childress, K. 16. Incidence of Hepatic Veno-Occlusive Disease Following Hematopoietic Stem Cell Transplant in Patients Treated with Norethindrone Acetate for Menstrual Suppression. Journal of Pediatric and Adolescent Gynecology. 2026; 39(2):356.

Hong, S; Espinoza-Gutarra, MR; Shah, R; Demartino, P; Davies, SM; Nemecek, E; Howard, D; Desalvo, AM; Meyer, CL; Majhail, NS; Preussler, J; Hall, AG; Arteaga, AG; Auletta, JJ; Khera, N. What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapy. Blood Reviews. 2026; 101417.

Huber, J; Alkhouli, L; Auletta, JJ; Bakinowski, E; Hunter, L; Bergman, E; Dandoy, CE; Degen, TA; Desalvo, AM; Diaz, J; Parker, L; Schei, T; Stuckey, R; Liang, WH. Operationalizing the CIBMTR Virtual Consortium Program to Advance Collaborative Quality Improvement in Transplant and Cellular Therapy. Transplantation and Cellular Therapy. 2026; 32(2):s562-s563.

Huber, J; Alkhouli, L; Dandoy, CE; Diaz, J; Hunter, L; Kent, G; Liang, WH; Maier, ST; Nguyen, A; Rotz, SJ; Epling, P; Parker, L; Hartley, D. A Multi-Center Self-Service Informatics Platform to Accelerate Quality Improvement in Transplant and Cellular Therapy: The Engraft Registry Power BI Dashboard. Transplantation and Cellular Therapy. 2026; 32(2):s560-s561.

Hudda, Z; Webster, A; Anderson, E; Badia, P; Bagatell, R; Bhar, S; Bidgoli, A; Boyd, K; Chaudhury, S; Cisneros, GS; Weiss, BD; Yazdani, S; Zheng, D; Dandoy, CE. Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplantation and Cellular Therapy. 2026; 32(2):199.e1-199.e12.

Ibrahimova, A; Luebbering, N; Strecker, L; Langenberg, L; Abdullah, S; Lake, KE; Wilhelm, J; Lane, A; Gloude, N; Myers, K; Dandoy, C; Towe, C; Khandelwal, P; Jodele, S; Davies, SM. Neutrophil extracellular traps, endothelial injury and use of abatacept for graft versus host disease prophylaxis. Haematologica. 2026.

Ibrahimova, A; Bidgoli, A; Ashraf, A; Krogman, A; Klink, G; Teusink-Cross, A; Schoettler, ML; Davies, SM; Khandelwal, P. Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults. Bone Marrow Transplantation. 2026; 61(4):487-489.

Ibrahimova, A; Badia, P; Davies, SM; Klink, G; Khandelwal, P. α1 – Antitrypsin for Treatment of Acute Graft Versus Host Disease in Children and Young Adults. Transplantation and Cellular Therapy. 2026; 32(2):s270.

Ikegami, S; Pandey, V; Wang, X; Sridharan, A; Mccormack-Spivey, S; Lutzko, CM; Cancelas, JA; Heyenbruch, D; Leemhuis, T; Alquist, CR; Khoury, R; Rubinstein, JD; Davies, S; Grimley, M. LONG-TERM CRYOPRESERVATION PRESERVES THE BIOLOGICAL AND MECHANOBIOLOGICAL ACTIVITY OF THIRD-PARTY VIRUS-SPECIFIC T CELLS. Cytotherapy. 2026; 28(5):102608.

Ivy, CJ; Klink, G; Teusink-Cross, A; Grimley, MS. Evaluating CMV Infection and Reactivation after Emapalumab: A Retrospective Evaluation of Letermovir Prophylaxis. Transplantation and Cellular Therapy. 2026; 32(2):s542.

Jodele, S. Targeting the lectin pathway in TA-TMA. Blood advances. 2026; 10(1):181-182.

Jodele, S; Mizuno, K; Sabulski, A; Dandoy, CE; Ramos, KN; Langenberg, L; Luebbering, N; Webster, A; Klink, G; Mclean, S; Davies, SM. Determinants of Eculizumab Response in High-Risk Transplant-Associated Thrombotic Microangiopathy. Transplantation and Cellular Therapy. 2026; 32(2):s104-s105.

Jose, A; Zacharias, W; Fernandes, S; Yasnogorodsky, M; Elwing, J; Ziady, A. (805) Sotatercept for the Treatment of Portopulmonary Hypertension. The Journal of Heart and Lung Transplantation. 2026; 45(5):375-376.

Jose, A; Zacharias, W; Fernandes, S; Yasnogorodsky, M; Elwing, J; Ziady, A. Sotatercept for the treatment of portopulmonary hypertension: a case report. Communications Medicine. 2026; 6(1).

Josephson, M; Allen, JL; Young, LR; Freedman, J; Towe, C; Koo, J; Myers, K; Woods, JC; Lane, A; Gaffin, JM; Houin, P; Macmillan, M; Davies, SM; Goldfarb, SB. A62-05 Longitudinal Measurement of Respiratory Function by Oscillometry in Children Following Hematopoietic Stem Cell Transplantation (hsct): A Report From the Transpire Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.2338.

Kapadia, M; Nishitani, M; Alkhouli, L; Badia, P; Blacken, R; Cook, E; Culbertson, C; Dandoy, CE; Daraiseh, N; Davies, SM; Staton, S; Stuckey, R; Young, K; Craddock, J. A Multicenter Quality Improvement Initiative to Reduce Central Venous Catheter Line Days after Transplant Cellular Therapy across the Engraft Learning Health Network. Transplantation and Cellular Therapy. 2026; 32(2):s360-s361.

Kapoor, U; Qayed, MD; Williams, KM; Schoettler, ML; Ibrahimova, A; Khandelwal, P; Krogman, A; Obordo, J; Bidgoli, A. Belumosudil-Induced Reductions in Sirolimus Dosing for Pediatric Chronic GVHD (cGVHD). Transplantation and Cellular Therapy. 2026; 32(2):s602-s603.

Kent, G; Alkhouli, L; Dandoy, CE; Davies, SM; Diaz, J; Huber, J; Maier, S; Nguyen, A; O'mathúna, D; Stuckey, R; Rotz, SJ; Parker, L; Juckett, MB. Overcoming Regulatory Barriers: A Case Study of IRB and Dua Navigation in the Engraft Learning Network. Transplantation and Cellular Therapy. 2026; 32(2):s516.

Kent, G; Alkhouli, L; Badia, P; Bakinowski, E; Blevins, C; Dandoy, CE; Davies, SM; Desalvo, AM; Huber, J; Juckett, MB; O'mathúna, D; Parker, L; Spears, K; Pai, AL. Mapping Mental Health Resource Gaps in Transplant Centers: A Multi-Center Comparison of Provider Perception Vs. Actual Availability in the Engraft Learning Network. Transplantation and Cellular Therapy. 2026; 32(2):s366.

Khandelwal, P; Haslam, D; Ibrahimova, A; Laskin, B; Webster, A; Blackard, JT; Lake, K; Hoerth, C; Luebbering, N; Abdullah, S; Davies, SM. The gut virome in children undergoing hematopoietic cell transplantation is diverse and a site for viral reactivation. Bone Marrow Transplantation. 2026.

Khawaja, F; Papanicolaou, GA; Grimley, MS; Gomez, CA; Mahadeo, KM; Elgarten, CW; Marón, GM; Lanier, R; Nielsen-Orzeck, I; Maher, R; Azie, N; Chemaly, RF. Intravenous Brincidofovir Effectively Reduces CMV Dnaemia In Antiviral Experienced Immunocompromised Patients: Results of a Phase 2a Clinical Trial. Transplantation and Cellular Therapy. 2026; 32(3):s19.

Klink, G; Mizuno, K; Teusink, A; Mclean, S; Davies, SM; Jodele, S. A Decade of Precision: PK/PD-Guided Eculizumab Therapy for TA-TMA Management. Transplantation and Cellular Therapy. 2026; 32(2):s615.

Koo, J; Webster, A; Lake, KE; Luebbering, N; Dandoy, C; Jodele, S; Ryan, TD; Davies, SM; Sabulski, A. Proteomic analysis of pericardial effusions in hematopoietic stem cell transplant recipients. Haematologica. 2026; 111(4):1484-1489.

Koo, J; Langenberg, L; Zhao, X; Setchell, KR; Lake, KE; Luebbering, N; Walter, E; Lane, A; Myers, KC; Reynaud, D; Sabulski, A; Teusink-Cross, A; Jodele, S; Davies, SM. Lipid dysregulation after hematopoietic stem cell transplant. Haematologica. 2026; 111(5):1634-1645.

Koo, J; Miller, E; O'conner, A; Myers, KC; Mehta, PA; Davies, SM. Radiation-Free Reduced-Intensity Conditioning Achieves Excellent Outcomes in Pediatric Severe Aplastic Anemia. Transplantation and Cellular Therapy. 2026; 32(2):s581.

Koo, J; Langenberg, L; Walter, E; Zhao, X; Setchell, K; Lake, KE; Khandelwal, P; Lane, A; Manjrekar, P; Myers, KC; Reynaud, D; Sabulski, A; Teusink-Cross, A; Jodele, S; Davies, SM. Lower Isn't Better: Baseline LDL-C Identifies Endothelial Vulnerability and Outcomes after HSCT. Elsevier; 2026:s594.

Koo, J; Schwarz, D; Haney, M; Putra, J; Kim, J; Cheng, L; Korn, E; Steltz, S; Schwarz, L; Loveless, S; Myers, KC; Shimamura, A; Grover, AS; Wehrman, A. Liver disease in Shwachman-Diamond syndrome: A comprehensive characterization across the age spectrum. Journal of Pediatric Gastroenterology and Nutrition. 2026; 82(6):1357-1365.

Langenberg, L; Ibrahimova, A; Jodele, S; Holtan, S; French, K; Davies, SM; Khandelwal, P. Serum Amphiregulin Differentiates Acute GI GVHD from Infectious Colitis. Transplantation and Cellular Therapy. 2026; 32(2):s248.

Lawhorn, E; Mani, B; Howell, JC; Davies, SM; Myers, K; Hudda, Z. Longitudinal Outcomes of Reproductive Function in Male Pediatric Hematopoietic Stem Cell Transplant Survivors. Transplantation and Cellular Therapy. 2026; 32(2):s356.

Liberio, N; Allbee-Johnson, M; Ahn, KW; Moskop, A; Phelan, R; Shaw, BE; Page, KM; Schultz, KR; Phillips, CL; Mehta, PA; Kapoor, N; Doherty, EE; Chavan, RS; Broglie, L. Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant. Journal of Clinical Oncology. 2026; 44(11):1003-1015.

Luebbering, N; Abdullah, S; Webster, A; Mccormack-Spivey, S; Koo, J; Jodele, S; Davies, SM; Sabulski, A. Pre-Transplant Inflammation Promotes Endothelial to Mesenchymal Transition in Pediatric TA-TMA. Transplantation and Cellular Therapy. 2026; 32(2):s604-s605.

Maier, ST; Dandoy, CE; Davies, SM; Gorfinkel, L; Huber, J; Jodele, S; Kapadia, M; Kent, G; Lehmann, LE; Myers, K; Nguyen, A; Nishitani, M; Parker, L; Epling, P. Activating Epic’s Flowsheet for Standardized Chronic GVHD Assessment: A Multi-Center Implementation Framework to Enable Standardized Documentation. Transplantation and Cellular Therapy. 2026; 32(2):s520-s521.

Manjrekar, P; Lies, E; Davies, SM; Laskin, B; Jodele, S; Sabulski, A. Kidney Injury Markers in Pediatric TA-TMA: In the World of Serum Creatinine, be a Cystatin C or Urine Protein. Transplantation and Cellular Therapy. 2026; 32(2):s588-s589.

Marsh, RA; Cowan, MJ. The evolving landscape of primary hemophagocytic lymphohistiocytosis: Long-term outcomes following hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology. 2026; 157(2):340-341.

Mccormack-Spivey, S; Walter, E; Langenberg, L; Jodele, S; Davies, SM; Sabulski, A. Serine Proteinase Inhibitor (Serpin) E1 As an Early Urine Biomarker of Subclinical Renal Fibrosis in Children with Transplant Associated Thrombotic Microangiopathy (TA-TMA) Transplantation and Cellular Therapy. 2026; 32(2):s589.

Mccormack-Spivey, S; Wilhelm, J; Ikegami, S; Rubinstein, JD; Hudda, Z; Khoury, R; Davies, SM; Grimley, MS. Duration of Cryopreservation of Third-Party Viral Specific T-Cells (TP-VSTs) Does Not Influence Clinical Efficacy. Transplantation and Cellular Therapy. 2026; 32(2):s131.

Mehta, RS; Wang, T; Pidala, JA; Huffman, C; Farhadfar, N; Defilipp, Z; Khandelwal, P; Spellman, SR; Lee, SJ; Jurdi, NE; Bejanyan, N. Calcineurin Inhibitor Versus Sirolimus As Immunosuppressive Partners with Ptcy-Based GVHD Prophylaxis in Adults Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancies: A CIBMTR Analysis. Transplantation and Cellular Therapy. 2026; 32(2):s264-s265.

Merkle, S; Ricci, K; Blache, K; Marsh, RA; Hammill, AM; Engel, E. Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus. Pediatric Blood and Cancer. 2026; 73(7):e70335.

Mishra, AK; Langenberg, L; Strecker, L; Zhao, Q; Jodele, S; Sabulski, A; Vasu, S; Bejanyan, N; Hahn, TE; Davies, SM. Transplant Associated Thrombotic Microangiopathy (TA-TMA) Is Mechanistically Different in Adults and Children- a MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium Study. Transplantation and Cellular Therapy. 2026; 32(2):s69.

Morales Junior, R; Hambrick, HR; Benoit, SW; Klink, G; Mizuno, T; Tang Girdwood, S. Population pharmacokinetics and Monte Carlo simulation of Cefepime in paediatric and Young adult bone marrow transplant patients. British Journal of Clinical Pharmacology. 2026; 92(7):2316-2325.

Morrison, A; Myers, K; Streich-Tilles, T. Human papillomavirus vaccine uptake among adolescent survivors of hematopoietic stem cell transplant. Journal of Cancer Survivorship. 2026; 20(3):1046-1054.

Munidasa, SR; Koo, J; Cooper, R; Hils, B; Edwards, SL; Myers, KC; Abts, MF; Lake, KE; Baker, SK; Doherty, EE; Goldfarb, S; Davies, SM; Deterding, RR; Woods, JC. B17-08 CT Predicts Lung-Related Events in Children Post-Hematopoietic Stem Cell Transplant: A TRANSPIRE Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.6570.

Munshi, PN; Yuen, C; Al-Juhaishi, T; Jensen, E; Nemecek, ER; Sandmaier, BM; Davies, SM; Auletta, JJ; Chakrabarty, JH. Breaking Access Barriers to Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies-an ASTCT-NMDP ACCESS Initiative. Transplantation and Cellular Therapy. 2026; 32(6):737-753.

Muruato, L; Towe, C; Myers, K. C60-05 The Utility of Bronchoscopy Prior to Bone Marrow Transplant in Children: A Retrospective Case Series. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.3527.

Myers, KC; Skala, EJ; Ghandikota, S; Jegga, AG; Mousa, N; Siefert, ME; Lane, A; Reffatto, V; Towe, C; Luebbering, N; Bridgeland, A; Goldfarb, S; Davies, SM; Ziady, AG. Blood proteomics of paediatric bronchiolitis obliterans syndrome after haematopoietic cell transplant. ERJ Open Research. 2026; 12(3).

Nelson, AS; Pence, L; Khandelwal, P; Jodele, S; Davies, SM; Huber, J; Benoit, SW. Endothelial Protection Reduces PRES in Pediatric Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2026; 32(2):s609.

Obermark, T; Debnath, P; Ayyala, RS; Danziger-Isakov, LA; Koo, J; Myers, KC; Otto, WR; Tanimoto, A; Trout, AT; Morin, CE. Utility of Computed Tomography Surveillance of Asymptomatic Infection in Children and Young Adults Before Allogeneic Hematopoietic Stem Cell Transplant. Pediatric Blood and Cancer. 2026; 73(5):e70175.

Omer, L; Gloude, NJ; Mcguinn, C; Nakano, TA; Overholt, K; Ogando-Rivas, E; Myers, KC; Broglie, LA; Hillier, K; Schaefer, E; Lipton, JM; Kurre, P; Castillo, P; De Jong, JLO. A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia Consortium. Journal of Pediatric Hematology/Oncology. 2026; 48(5):230-236.

Orange, JS; Chinen, J; Horner, CC; Kobrynski, LJ; Ballow, M; Butte, MJ; Chandrakasan, S; Chinn, IK; Satter, LF; Freeman, AF; Greenhawt, M; Ledford, DK; Mosnaim, G; Wang, J. 2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS). Annals of Allergy, Asthma and Immunology. 2026; 136(4):426-493.e1.

Otto, W; Rickerman, L; Leon, MD; Huang, FS; Sankaranarayanan, K; Dandoy, C; Lamson, DM; Kajon, AE. A Pediatric Case of Rapidly Progressing Disseminated Human Adenovirus C1 Infection with Multiorgan Failure and Evidence of Intra-Host Variation. Viruses. 2026; 18(6).

Parenti, MB; Allen, J; Young, LR; Boas, H; Freedman, J; Towe, C; Koo, J; Myers, K; Woods, JC; Lane, A; Robinson, PD; Macmillan, M; Davies, SM; Goldfarb, SB. Respiratory profile of pediatric patients undergoing hematopoietic stem cell transplantation studied by oscillometry – A TRANSPIRE cohort. Pediatric Investigation. 2026.

Pence, L; Huber, J; Jodele, S; Davies, SM; Benoit, SW. Posterior Reversible Encephalopathy Syndrome in a Pediatric Hematopoietic Stem Cell Transplant Cohort: Characteristics and Associated Complications. Transplantation and Cellular Therapy. 2026; 32(2):s600.

Ramos, KN; Langenberg, L; Lake, KE; Hoerth, C; Luebbering, N; Haslam, D; Newburg, D; Morrow, AL; Ollberding, NJ; Teusink, A; Watanabe-Chailland, M; Romick-Rosendale, L; Davies, SM; Khandelwal, P. 2’-Fucosyllactose (Human Milk Oligosaccharide) Reduces Dysbiosis and Acute GI GVHD in Children and Young Adults Following HSCT: A Prospective, Single-Center Phase II Study. Transplantation and Cellular Therapy. 2026; 32(2):s570.

Rangarajan, HG; Stenger, EO; Shenkar, R; Stanek, J; Alzaharani, M; Hsieh, M; Limerick, E; Darrigo, LG; Bonfim, C; Bhatia, M; Horan, J; Guilcher, GM; Kassim, AA; Abraham, A. Outcomes Following Graft Failure and Second Subsequent Allogeneic Hematopoietic Cell Transplant in Patients with Sickle Cell Disease: A Multicenter Study. Transplantation and Cellular Therapy. 2026; 32(2):s18-s19.

Rangarajan, HG; Chellapandian, D; Atshan, R; Ahn, KW; Kumar, S; Knight, TE; Leung, W; Ganguly, S; Williams, KM; Shah, NN; Qayed, M; Sharma, A; Broglie, L; Satwani, P. Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults With Acute Myeloid Leukemia: A CIBMTR Report. Transplantation and Cellular Therapy. 2026; 32(5):580.e1-580.e18.

Rayes, A; Logan, BR; Liu, X; Dara, J; Buckley, RH; Oved, JH; Kapoor, N; Kapadia, M; Chandra, S; Martinez, CA; Heimall, J; Haddad, E; Pai, S-Y; Dvorak, CC. Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC. Blood advances. 2026; 10(3):887-900.

Sabulski, A; Webster, A; Langenberg, L; Luebbering, N; Myers, KC; Dandoy, CE; Libermann, TA; Dillon, ST; Gu, X; Clark, DM; Snyder, AJ; Jodele, S; Davies, SM. Plasma proteomics and single-cell RNA-seq identify cellular and soluble mechanisms of graft rejection after HSCT. Blood Immunology & Cellular Therapy. 2026; 2(2):100046.

Sabulski, A; Webster, A; Mizuno, K; Luebbering, N; Davies, SM; Jodele, S. Multiomics Reveal Interferon-Induced Cell Senescence As a Novel Mechanism of Eculizumab Resistance in TA-TMA. Transplantation and Cellular Therapy. 2026; 32(2):s594-s595.

Sabulski, A; Mccormack-Spivey, S; Webster, A; Strecker, L; Laskin, B; Blackard, JT; Walder, T; Hurst, T; Seif, AE; Jodele, S; Davies, SM. A Multiomic Study Reveals Pilra, Monocytes and Interferons Put the “Itis” in BK Polyomavirus Cystitis. Transplantation and Cellular Therapy. 2026; 32(2):s95.

Smiley, NP; Lane, A; Webster, A; Blank, C; Hawkins, C; Hassall, T; Leach, J; Dorris, K; Jones, B; Hansford, JR; Zaghloul, M; Cheng, S; Hummel, TR; Hoffman, LM; Warren, KE. Re-irradiation practices and outcomes in patients with diffuse intrinsic pontine glioma (DIPG): A report from the International DIPG/DMG Registry. Neuro-Oncology Pediatrics. 2026; 2(2):wuag013.

Spears, K; Alkhouli, L; Badia, P; Cook, E; Dandoy, CE; Davies, SM; Huber, J; Kapadia, M; Kent, G; Klinger, J; Parker, L; Snyder, AJ; Staton, S; Maier, S. Quantifying the Cost and Practice Variation of Central Venous Catheter Maintenance across the Engraft Learning Health Network. Transplantation and Cellular Therapy. 2026; 32(2):s475-s476.

Strecker, L; Abts, MF; Freedman, J; Baker, K; Doherty, E; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Josephson, M; Young, LR; Zinter, M; Davies, SM; Ibrahimova, A. C74-09 MCP-1 in Broncho-Alveolar Fluid and Plasma in Children With Lung Injury After Hematopoietic Stem Cell Transplant: A Transpire Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.5449.

Strecker, L; Mishra, A; Abts, MF; Freedman, J; Baker, K; Doherty, E; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Young, LR; Zinter, M; Davies, SM; Ibrahimova, A. B101-02 To Bronch or Not to Bronch? - Biologic Markers of Lung Injury in the Bronchoalveolar Lavage Fluid of Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, a Transpire Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.5393.

Strecker, L; Abts, MF; Baker, KS; Freedman, JL; Doherty, EE; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Josephson, MB; Young, LR; Zinter, MS; Davies, SM; Ibrahimova, A. MCP-1 in Broncho-Alveolar Fluid and Plasma in Children with Lung Injury after Hematopoietic Stem Cell Transplant: A Transpire Study. Transplantation and Cellular Therapy. 2026; 32(2):s581-s582.

Strecker, L; Mishra, AK; Abts, MF; Freedman, JL; Baker, S; Doherty, EE; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Young, LR; Zinter, MS; Davies, SM; Ibrahimova, A. “to Bronch or Not to Bronch? - Biologic Markers of Lung Injury in the Bronchoalveolar Lavage Fluid of Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, a Transpire Study. Transplantation and Cellular Therapy. 2026; 32(2):s584-s585.

Taggart, CB; Bota, KE; Ramos, KN; Dandoy, CE; Davies, SM. From Standard Formulas to Individualize Care: Optimizing HSCT Nutrition through Metabolic Cart Assessments. Transplantation and Cellular Therapy. 2026; 32(2):s595-s596.

Taylor, AO; Hong, S; Jones, S; Ng, K; Gooley, TA; Bhatt, N; Hellewell, EM; Sung, AD; Ahmed, N; Morey, C; Yingling, S; Edgar, CM; Browning, AL; Lee, CJ. Relationship between Social Drivers of Health and Clinician Adherence to Late Effects Screening Among Allogeneic HCT Survivors in the United States. Transplantation and Cellular Therapy. 2026; 32(2):s24-s25.

Thant, MM; Gollamudi, J; Benoit, SW; Chonat, S; Cancelas, JA. Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course. British Journal of Haematology. 2026; 208(6):2311-2314.

Trapnell, BC; Arumugam, PI; Carey, BC; Krischer, J; Suzuki, T; Wessendarp, M; Trump-Durbin, L; Lutzko, C; Towe, C; Burg, G; Davies, SM; Imbrogno, M; Stock, J; Wood, RE. B95-10 A First-in-human Study of Pulmonary Macrophage Transplantation Therapy of Hereditary Pulmonary Alveolar Proteinosis. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_2):aamag286.181.

Urrego, F; Josephson, M; Allen, JL; Young, LR; Towe, C; Koo, J; Myers, K; Woods, JC; Lane, A; Gaffin, JM; Robinson, PD; Houin, P; Davies, SM; Goldfarb, SB. A62-04 Comparison of Home Spirometry to Office Spirometry in Children and Young Adults Post Hematopoietic Stem Cell Transplant in the Transpire Research Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.2957.

Verkamp, B; Jordan, MB; Allen, CE. Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment. Blood. 2026; 147(10):1019-1036.

Verkamp, B; Bota, KE; Taggart, CB; Ashraf, A; Klink, G; Langenberg, L; Jodele, S; Davies, SM; Khandelwal, P. C You Later, Endothelial Injury! Low Vitamin C Post-Hematopoietic Cell Transplant Predisposes to Endothelial Injury and Overall Mortality in Children. Transplantation and Cellular Therapy. 2026; 32(2):s586-s587.

Vichare, V; Kilich, G; Cunningham-Rundles, C; Onyekaba, M; Abraham, RS; Puck, J; Fuleihan, R; Marsh, RA; Sullivan, KE. Automated data extraction model for the USIDNET registry: Bigger, faster, and better data collection. Journal of Human Immunity. 2026; 2(1):e20250118.

Vucianis, T; Foster, KE; Nakamura, A; Hossain, M; Gover, I; Diebold, S; Towe, C; Ruff, K; Burg, G; Hardie, WD; Myers, K; Hayes, D; Paisley, A. A99-07 Benefits of Pulmonary Rehabilitation for Pediatric Chronic Respiratory Disease. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.6106.

Walder, TA; Hillenbrand, CA; Hirsch, HH; Starrett, GJ; Sabulski, A; Buck, CB; Justice, J; Laskin, BL; Davies, SM; Blackard, JT. Insight Into Current BK Polyomavirus Research Efforts: BK Day Meeting 2024. Transplantation. 2026; 110(5):e948-e951.

Ware, RE; Opoka, RO; Latham, T; Kasirye, P; Kasembo, P; Hume, H; Birungi, I; Kadde, N; Wambaka, B; Nakafeero, M; Conroy, AL; Tomlinson, G; Lane, A; John, C. Ten Years of Hydroxyurea for Ugandan Children with Sickle Cell Anemia. New England Journal of Medicine. 2026; 394(20):2059-2061.

Weldengus, TM; Liu, B; Kou, F; Lyu, Y; Chen, J; Fan, Q; Zou, C. InstantRetouch: Personalized Image Retouching without Test-time Fine-tuning Using an Asymmetric Auto-Encoder. . 2026; abs/2602.17044.

Wong, W; Josephson, M; Allen, JL; Young, LR; Abts, MF; Houin, P; Deterding, RR; Urrego, F; Carmona, MDS; Towe, C; Macmillian, M; Eissa, H; Cisneros, GS; Goldfarb, SB. A62-07 Transpire: Acute Worsening in DLCO Followed by Rebounding Longitudinal Improvement After Pediatric Hematopoietic Stem Cell Transplant in a Multicenter Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.2339.

Wudhikarn, K; Gowda, L; Ye, Q; Oloyede, T; Martens, M; Banerjee, R; Devarakonda, SS; Liu, H; Herr, MM; Young, J-AH; Akhtar, OS; Auletta, JJ; Huppler, AR; Abid, MB. Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR Analysis. Transplantation and Cellular Therapy. 2026.

Zhou, Z; Wang, T; Mccurdy, SR; Nath, R; Huffman, C; Farhadfar, N; Defilipp, Z; Khandelwal, P; Spellman, SR; Jurdi, NE; Lee, SJ; Munshi, PN. Post-Transplant Cyclophosphamide Versus Calcineurin Inhibitor and Methotrexate GVHD Prophylaxis, with or without ATG, in HLA-Matched Related and Unrelated Donor Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies Undergoing Reduced-Intensity Conditioning: A CIBMTR Analysis of 5,950 Participants. Transplantation and Cellular Therapy. 2026; 32(2):s260-s261.

Zoref-Lorenz, A; Allen, CE; Behrens, EM; Chandrakasan, S; Chien, M; Hermiston, ML; Hinson, AP; Intzes, S; Isakoff, MS; Leiding, JW; Modica, R; Riskalla, M; Baker, A; Ward, B. Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study. Blood advances. 2026; 10(5):1564-1575.